Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Su

Showing results (71-80 of 223) with videos related to

Pageof 23
Sort By:
International Journal of Nanomedicine|January 29, 2025
LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB TherapyYajuan Yan, Ting Duan, Xiaonan Xue, et al.
Translational Lung Cancer Research|May 19, 2020
Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancerTao Jiang, Ruirui Cheng, Yuanwei Pan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2021
The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patientsFei Zhou, Yan Huang, Weijing Cai, et al.
ACS Applied Materials & Interfaces|June 10, 2026
Potentiating Paclitaxel with its Homologous Nanovesicles: A Synergistic Strategy for Triple-Negative Breast Cancer TherapyLi Liu, Yajuan Yan, Jiao Zhang, et al.
Medical Oncology (Northwood, London, England)|March 19, 2010
BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancerZhanxia Li, Songwen Zhou, Ling Zhang, et al.
Biomaterials Research|December 15, 2025
Bioengineered Anti-PD-L1 Functionalized Nanoplatform for Targeted Delivery and Tumor Immune Reprogramming Against Colorectal CancerMiao Liu, Xinjuan Ma, Ruijie Zhou, et al.
International Journal of Clinical and Experimental Pathology|June 6, 2015
High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patientsChao Zhao, Xuefei Li, Chunxia Su, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2018
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysisTao Jiang, Meng Qiao, Chao Zhao, et al.
Free Radical Biology & Medicine|August 22, 2025
Epimedokoreanin B blocks autophagic flux to inhibit progression of triple negative breast cancer through targeting MCOLN1/TRPML1 channelChenyang Zhao, Peng Zhang, Xiaojuan Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2016
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain MetastasesTao Jiang, Chunxia Su, Xuefei Li, et al.
Pageof 23

Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
International Journal of Nanomedicine|January 29, 2025
LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB TherapyYajuan Yan, Ting Duan, Xiaonan Xue, et al.
Translational Lung Cancer Research|May 19, 2020
Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancerTao Jiang, Ruirui Cheng, Yuanwei Pan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2021
The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patientsFei Zhou, Yan Huang, Weijing Cai, et al.
ACS Applied Materials & Interfaces|June 10, 2026
Potentiating Paclitaxel with its Homologous Nanovesicles: A Synergistic Strategy for Triple-Negative Breast Cancer TherapyLi Liu, Yajuan Yan, Jiao Zhang, et al.
Medical Oncology (Northwood, London, England)|March 19, 2010
BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancerZhanxia Li, Songwen Zhou, Ling Zhang, et al.
Biomaterials Research|December 15, 2025
Bioengineered Anti-PD-L1 Functionalized Nanoplatform for Targeted Delivery and Tumor Immune Reprogramming Against Colorectal CancerMiao Liu, Xinjuan Ma, Ruijie Zhou, et al.
International Journal of Clinical and Experimental Pathology|June 6, 2015
High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patientsChao Zhao, Xuefei Li, Chunxia Su, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2018
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysisTao Jiang, Meng Qiao, Chao Zhao, et al.
Free Radical Biology & Medicine|August 22, 2025
Epimedokoreanin B blocks autophagic flux to inhibit progression of triple negative breast cancer through targeting MCOLN1/TRPML1 channelChenyang Zhao, Peng Zhang, Xiaojuan Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2016
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain MetastasesTao Jiang, Chunxia Su, Xuefei Li, et al.
Pageof 23